Pharmacological combinations for the treatment of Duchenne muscular dystrophy

摘要

A combination comprising (or essentially consisting of) the compound 5- (ethylsulfonyl) -2- (naphthalen-2-yl) benzo [d] oxazole and a corticosteroid selected from prednisone, prednisolone and deflazacort.